Microbix Biosystems (TSE:MBX) Stock Price Crosses Above Fifty Day Moving Average – Should You Sell?

Shares of Microbix Biosystems Inc. (TSE:MBX) crossed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of C$0.23 and traded as high as C$0.24. Microbix Biosystems shares last traded at C$0.24, with a volume of 9,400 shares trading hands.

Microbix Biosystems Price Performance

The company has a debt-to-equity ratio of 30.47, a current ratio of 7.51 and a quick ratio of 5.57. The business’s fifty day moving average price is C$0.23 and its 200-day moving average price is C$0.24. The stock has a market capitalization of C$32.56 million, a price-to-earnings ratio of -7.83 and a beta of 0.40.

Microbix Biosystems (TSE:MBX) last issued its quarterly earnings data on Thursday, February 12th. The company reported C($0.01) EPS for the quarter. Microbix Biosystems had a negative return on equity of 14.88% and a negative net margin of 25.48%.The company had revenue of C$4.22 million during the quarter. On average, research analysts forecast that Microbix Biosystems Inc. will post 0.02 EPS for the current year.

Microbix Biosystems Company Profile

Microbix develops proprietary biological technology solutions for human health and well-being, with about 90 skilled employees and sales growing from a base of over $1 million per month. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows.